(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZANAFLEX CAPSULES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZANAFLEX CAPSULES

ST13

US500000078713378

Class

5

Filing

78713378

Registration

3341341

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

57

Latest update

01/28/2026

Trademark type

Word

Nice classes

5

Filing date

09/15/2005

Registration date

11/20/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/29/2017

Last transaction

01/28/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/04/2005

First use in commerce

04/04/2005

Drawing code

4

Owner type

26

Owner location

CHRIST CHURCH, BB

Examiner

BUTTON, JENNIFER JO

Law office

M40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

COVIS PHARMA B.V.
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.
Elan Pharmaceuticals, Inc.

Representatives

Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations containing tizanadine hydrochloride for the treatment of neurological disorders

Publications

History of USPTO decisions and trademark events.

57 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/27/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/17/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/05/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/05/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/05/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/05/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/05/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/05/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/05/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/02/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/01/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/11/2023

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/26/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/23/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/19/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/09/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/24/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/17/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/07/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/07/2017

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/29/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/29/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/29/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/28/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

10/31/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/20/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/30/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/30/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/30/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

11/18/2013

E815

TEAS SECTION 8 & 15 RECEIVED

11/18/2013

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/21/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

11/20/2007

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/16/2007

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

10/15/2007

ALIE

ASSIGNED TO LIE

10/15/2007

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/13/2007

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/24/2007

IUAF

USE AMENDMENT FILED

07/18/2007

EISU

TEAS STATEMENT OF USE RECEIVED

07/18/2007

EX1G

SOU EXTENSION 1 GRANTED

02/27/2007

EXT1

SOU EXTENSION 1 FILED

02/27/2007

EEXT

SOU TEAS EXTENSION RECEIVED

02/27/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

08/29/2006

PUBO

PUBLISHED FOR OPPOSITION

06/06/2006

NPUB

NOTICE OF PUBLICATION

05/17/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/18/2006

ALIE

ASSIGNED TO LIE

04/18/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/28/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

03/27/2006

GNEA

EXAMINERS AMENDMENT E-MAILED

03/27/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/27/2006

DOCK

ASSIGNED TO EXAMINER

03/24/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

11/08/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/26/2005

MAIL

PAPER RECEIVED

10/26/2005

NWAP

NEW APPLICATION ENTERED

09/22/2005

Continuous trademark protection

Get notified about every new filing that threatens ZANAFLEX CAPSULES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.